ETF Managers Group’s Assembly Biosciences ASMB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$13.7K Buy
1,360
+347
+34% +$5.85K ﹤0.01% 682
2022
Q4
$15.8K Sell
1,013
-178
-15% -$3.04K ﹤0.01% 512
2022
Q3
$23K Sell
1,191
-78
-6% -$1.89K ﹤0.01% 685
2022
Q2
$32K Buy
1,269
+59
+5% +$1.36K ﹤0.01% 726
2022
Q1
$30K Buy
1,210
+4
+0.3% +$86 ﹤0.01% 676
2021
Q4
$33K Sell
1,206
-162
-12% -$5.31K ﹤0.01% 675
2021
Q3
$57K Buy
1,368
+381
+39% +$16K ﹤0.01% 652
2021
Q2
$46K Buy
987
+10
+1% +$495 ﹤0.01% 638
2021
Q1
$53K Sell
977
-362
-27% -$24K ﹤0.01% 650
2020
Q4
$98K Sell
1,339
-194
-13% -$22.8K ﹤0.01% 599
2020
Q3
$299K Buy
1,533
+694
+83% +$175K 0.01% 476
2020
Q2
$236K Buy
+839
New +$196K 0.01% 532

Other funds holding ASMB

ETF Managers Group's ASMB Position: Q1 2023 in Review

ETF Managers Group increased its Assembly Biosciences (ASMB) stake by 34% in Q1 2023, buying an estimated $5.85K and bringing the position to 1,360 shares worth $13.7K. The position accounts for ﹤0.01% of the portfolio, ranked #682.

ETF Managers Group first reported a position in ASMB in Q2 2020 and has held it in 12 quarters since. The position peaked at $299K in Q3 2020. 37 funds tracked by Wall St. Rank hold ASMB as of Q1 2023.

  • ETF Managers Group held 1,360 shares of Assembly Biosciences worth $13.7K as of Q1 2023.
  • ETF Managers Group bought 347 Assembly Biosciences shares in Q1 2023, an estimated $5.85K.
  • Assembly Biosciences made up ﹤0.01% of ETF Managers Group's portfolio in Q1 2023, its #682 holding.
  • ETF Managers Group first reported a position in Assembly Biosciences in Q2 2020 and has held it in 12 quarters since.
  • ETF Managers Group's Assembly Biosciences position peaked at $299K in Q3 2020.
  • 37 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2023.

Based on ETF Managers Group's 13F filing for Q1 2023, filed 18 Apr 2023.